Handelsavisen
prelaunch
Companies ›Industrials ›2159.HK
21
2159.HK — HKEX Business Support Services

Mediwelcome Healthcare Management & Technology Inc

HK$1,58
Open in Charts → Attach watcher ⌖
— —
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
442,4M HKD
P/E
—
EV / Rev
—
Div yield
—
Op margin
2,1 %
ROE
9,0 %
Net margin
2,1 %
Debt / equity
0,49
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

Mediwelcome Healthcare Management & Technology Inc provides business support services in the healthcare sector, primarily generating revenue through healthcare management and technology solutions.

Business. Mediwelcome Healthcare Management & Technology Inc (2159.HK) is a business support services provider operating within the Industrial & Commercial Services sector. The company is listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data.

Classification92 %
SectorIndustrials
Business sectorIndustrial & Commercial Services
IndustryBusiness Support Services
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
9,0 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 2159.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials · THIS SECTOR−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 2159.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Mediwelcome Healthcare Management & Technology Inc (2159.HK) is a business support services provider operating within the Industrial & Commercial Services sector. The company is listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data.

    Classification92 %
    SectorIndustrials
    Business sectorIndustrial & Commercial Services
    IndustryBusiness Support Services
    AI synthesis
    GENERATED

    Mediwelcome Healthcare has a market price of 1.59 and a market cap of 445.2 million, with a price-to-earnings ratio of 44.57 and a price-to-book ratio of 4.0. The company's liquidity position is characterized by a current ratio of 1.89, indicating a moderate ability to meet short-term obligations. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.

    In terms of profitability, the company's return on equity is 8.98%, and its return on assets is 5.24%. These figures are below the industry median for healthcare providers and services, suggesting that Mediwelcome is underperforming relative to its peers in terms of capital efficiency and asset utilization.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes, which could impact its revenue stability.

    Looking at the company's growth trajectory, there is no disclosed revenue growth in the current fiscal year, and no specific numeric deltas are provided for the next fiscal year. The company's capital expenditure is minimal, with a value of -421,000, indicating a low level of investment in new projects or infrastructure.

    The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to raise additional capital or manage its debt more effectively to maintain liquidity. The dilution potential is low, as the number of shares outstanding remains unchanged between basic and diluted shares.

    Recent events and filings do not provide specific details on the company's operations or strategic initiatives. The company's financial statements and disclosures are limited to the data provided, with no additional information on recent business developments or management commentary.

    Key takeaways
    • Mediwelcome Healthcare has a high price-to-earnings ratio, indicating that the market may be valuing the company's earnings at a premium.
    • The company's return on equity and return on assets are below the industry median, suggesting inefficiencies in capital and asset utilization.
    • The company's liquidity position is moderate, with a current ratio of 1.89, but its net cash position is negative after subtracting total debt.
    • The company's capital expenditure is minimal, indicating a low level of investment in growth initiatives.
    • The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
    • **margin_outlook_rationale**: The company's gross profit margin is 20.23%, which is below the industry median, indicating potential cost management issues.
    • **rd_outlook_rationale**: No specific information is provided on the company's research and development activities or future outlook.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    HK$1,58
    Market cap
    HK$445.2M
    Enterprise valueⓘ
    HK$470.8M
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    121.8x
    P / Bⓘ
    4.0x
    P / Tangible bookⓘ
    4.0x
    Tangible book
    HK$111.3M
    Net cashⓘ
    -HK$25.6M
    Current ratioⓘ
    1.9
    Debt / equityⓘ
    0.5
    ROAⓘ
    5.2%
    ROEⓘ
    9.0%
    Cash conversionⓘ
    39.0%
    CapEx / revenueⓘ
    -0.1%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin2,1 %Bottom quartile
    Net Margin2,1 %Below median
    ROE9,0 %Above median
    Capex / Rev-0,1 %Above P75
    D/E0,49Below median
    Cash Conv0,39Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • Mediwelcome Healthcare Management & Technology Inc Market data — financials · 2026-05-26

    Ownership & reference

    Leadership

    • Liang WangChief Executive Officer, Executive Director
    • Wei ShiExecutive Chairman of the Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    2159.HKCanonical
    HKEX · HKD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage